ライフサイエンスコーパス: bednet

1 isruption of delivery of insecticide-treated bednets.

2 eractions between vaccination and the use of bednets.

3 ic interactions between vaccines and treated bednets.

4 mine the interaction between vaccination and bednets.

5 ally of immunisation and insecticide-treated bednets.

6 iron fortification, and insecticide-treated bednets.

7 istance, and coverage of insecticide-treated bednets.

8 e evidence for these evolving so as to avoid bednets.

9 onia, and malaria (23%), insecticide-treated bednets (20%), vaccines (17%), reductions in wasting (11

10 e to the introduction of insecticide-treated bednets (25%); improvements in nutritional status (19%);

11 tion; approaches such as insecticide-treated bednets and epidemic preparedness may be needed to preve

12 both in women who owned insecticide-treated bednets and in women who did not.

13 increased deployment of insecticide-treated bednets and increased availability of highly effective a

14 control measures such as insecticide-treated bednets and indoor residual spraying are insufficient or

15 at target indoor-resting mosquitoes, such as bednets and insecticides, are currently the cornerstone

16 ent will be used in conjunction with treated bednets and other forms of malaria control.

17 All children used bednets and received a single dose of sulfadoxine-pyrime

18 Participants were given insecticide-treated bednets, and caregivers were encouraged to bring their c

19 resistance changes the efficacy of standard bednets, and those containing the synergist piperonyl bu

20 Long lasting pyrethroid treated bednets are the most important tool for preventing malar

21 ndoor-residual spraying, insecticide-treated bednets) are therefore inappropriate.

22 re randomized to receive insecticide-treated bednets at the start of phase 1 (111 villages) or phase

23 ind that the combination of BSV with treated bednets can lead to increased morbidity with no added va

24 We then investigated optimal vaccination and bednet control programs under two endemic settings with

25 Switching to PBO bednets could avert up to 0.5 clinical cases per person

26 The personal protection provided by a bednet decreased over the study period and was lowest in

27 ng tablet administration, malaria treatment, bednet distribution, family planning, growth monitoring,

28 the course of 4 years surrounding nationwide bednet distribution.

29 ore individuals are indoors and protected by bednets, followed by a return to preintervention biting

30 1.04-1.16; p=0.001), and baby sleeping under bednet for 8-56 days (4548 [79%] of 5756 vs 4291 [73%] o

31 ard vaccinations ($12.96-25.93 per DALY) and bednets for malaria prevention ($6.48-22.04 per DALY).

32 The combination of TBV with treated bednets is synergistic, lowering both morbidity and elim

33 Insecticide-treated bednets (ITNs) are effective in preventing malaria where

34 the mass distribution of insecticide treated bednets (ITNs).

35 a standard long-lasting deltamethrin-coated bednet (PermaNet 2.0).

36 New bednets provide substantial personal protection until hi

37 cast a cloud over control measures, such as bednet provision and insecticide spraying, by implying t

38 Insecticide-treated bednets reduce malaria transmission and child morbidity

39 77% lower than in a neighboring area without bednets (risk ratio, 0.23; 95% confidence interval [CI],

40 malarial prophylaxis and insecticide-treated bednets should decrease stillbirths.

41 r health products (e.g., insecticide-treated bednets, soap, and water disinfectant) were marketed in

42 on throughout much of Africa is dependent on bednets that are impregnated with pyrethroid insecticide

43 re is strong synergy between PEV and treated bednets that may facilitate elimination, although transi

44 tion and distribution of insecticide-treated bednets timed to coincide with the 2015 malaria transmis

45 ri equivalence criteria in a setting of high bednet use (90.5%).

46 Increases were also noted in bednet use during pregnancy (5398 [69%] of 7859 vs 5135

47 There is no evidence that bednet use from birth increases all-cause mortality in o

48 8 unadjusted paired estimates; estimates of bednet use in 2009 met a priori equivalence criteria in

49 Adherence to bednet use in children younger than 5 years increased fr

50 Previous investigators have suggested that bednet use might paradoxically increase mortality in old

51 inations, estimates for behaviors other than bednet use remained substantially different.

52 it added to that of a single dose of SP and bednet use was modest.

53 t differ during 2002 (after up to 6 years of bednet use) between children from former intervention an

54 Studied health behaviors were bednet use, obtaining care for fever, obtaining care for

55 After 3 to 4 years of bednet use, the mean number of Anopheles mosquitoes per

56 , and 442 (88%) reported insecticide-treated bednet use.

57 ublic health benefits of insecticide-treated bednets were sustained for up to 6 years.

58 an area with low use of insecticide-treated bednets, were randomly assigned to receive full screenin